
Dear Colleagues,
We cordially invite you to join us at the 2nd International Online Conference on Personalized Medicine (IOCPM 2027), which will be hosted online from 20 to 21 October 2027.
Personalization to the individual’s specific condition has been integral to clinical medicine since ancient times; however, the possibilities of a truly personal approach to diagnosis and therapy have been limited. Now, in the most recent decade, interest in Personalized Medicine has exploded, with over 45,000 publications integrating advances in all biomedical sciences in every branch of medicine, toward the goals of more individualized diagnosis, therapy, and continuing care.
IOCPM 2027 will be a major forum for physicians and scientists, worldwide, to present and discuss advances at the frontier of Personalized Medicine.
IOCPM 2027 is designed to encompass the breadth and depth of topics currently most relevant to Personalized Medicine. Presentations will be channeled into four sessions:
S1. Disease Mechanisms for Personalized Medicine
S2. Personalized Diagnostics, Therapeutics, and Personalized Preventative Medicine
S3. Pharmacogenomics, Multi-Omics, and Informatics for Personalized Medicine
S4. Personalized and Precision Oncology
IOCPM 2027 will enable you to share and discuss your most recent research findings in Personalized Medicine with the vibrant global community of scientists and physicians in the field.
IOCPM 2027 will make your presentation accessible to hundreds of researchers worldwide, with the active engagement of the audience in question-and-answer sessions and discussion groups that will take place online.
The conference committee will review all submitted abstracts. The authors of accepted contributions will have their work displayed in an abstract collection. Following the conference, outstanding contributions will be invited to be submitted as a full-length paper for publication in the Journal of Personalized Medicine (ISSN: 2075-4426; CiteScore: 7.2).
IOCPM 2027 promises to be a most exciting conference, which we anticipate will become a transformative landmark in Personalized Medicine. We hope you will join us, present your work, contribute to discussions, and meet new colleagues. Together at IOCPM 2027, we will shape the future of Personalized Medicine.
Best wishes,
Prof. Dr. Kenneth P. H. Pritzker
Professor Emeritus,
Laboratory Medicine and Pathobiology;
Department of Surgery, Temerty Faculty of Medicine,
University of Toronto, Toronto, Canada
Conference Chair of the 2nd International Online Conference on Personalized Medicine
More News about MDPI Conferences

Laboratory Medicine and Pathobiology; Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada;Dr. Pritzker is Professor Emeritus in the Department of Laboratory Medicine and Pathobiology; Department of Surgery, Temerty Faculty of Medicine, and the Institute of Biomedical Engineering, University of Toronto and is Honorary Staff , Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto. Dr. Pritzker served as Chief, Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto from 1986 to 2008. With over 290 scientific publications and 27 book chapters, Ken is a recognized leader internationally in the fields of arthritis, biomaterials, genomics, cancer diagnostics and nanotechnology. Dr. Pritzker served on the External Advisory Board, Institute of Microstructural Sciences, National Research Council of Canada, 2005-2011. Dr. Pritzker serves as editor-in-chief, Journal of Personalized Medicine.
18 Jun
2027 (23:59 AoE)
20 Aug
2027 (23:59 AoE)
14 Oct
2027 (23:59 AoE)